G Protein News and Research

RSS

TSRI scientists discover new method for harnessing venoms for therapeutic use

There are lessons to be learned from venoms. Scorpions, snakes, snails, frogs and other creatures are thought to produce tens or even hundreds of millions of distinct venoms. These venoms have been honed to strike specific targets in the body.

26 May 2016

Alzheimer’s research raises questions on the role of infection

A new study has shown that A-beta (Aβ), the protein that forms β-amyloid plaques in Alzheimer’s disease, is a normal part of the immune system - raising questions about the role infection plays in Alzheimer’s disease and whether current treatment strategies should be changed.

26 May 2016

Researchers partially restore lost function of isolated cystic fibrosis lung cells

In experiments with isolated cystic fibrosis lung cells, University of Alabama at Birmingham researchers and colleagues from two other institutions have partially restored the lost function of those cells.

26 May 2016

Majority of young adults with abdominal obesity unaware of CKD risk

Many young adults with abdominal obesity exhibit a readily detectable risk factor for chronic kidney disease (CKD), yet the vast majority don't know they're at risk, according to a study of nationwide health data led by Albert Einstein College of Medicine researchers that was published online today in the journal PLOS ONE.

26 May 2016

Pre-treatment with antihistamines may suppress gastrointestinal symptoms of food allergy

Simultaneous pre-treatment with antihistamines that block both the H1 and H4 antihistamine receptors suppressed the gastrointestinal symptoms of food allergy in mice, according to researchers at National Jewish Health.

26 May 2016

First large-scale proteogenomic study helps pinpoint genes that drive breast cancer

Building on data from The Cancer Genome Atlas project, a multi-institutional team of scientists has completed the first large-scale "proteogenomic" study of breast cancer, linking DNA mutations to protein signaling and helping pinpoint the genes that drive cancer.

26 May 2016

SBP scientists discover new regulator of immune responses

Research led by scientists at the Sanford Burnham Prebys Medical Discovery Institute has identified a new regulator of immune responses. The study, published recently in Immunity, sheds new light on why T cells fail to clear chronic infections and eliminate tumors.

26 May 2016

Common pain and anti-inflammation drugs may slow cancer growth

Scientists from the Florida campus of The Scripps Research Institute have found that one of the most widely prescribed pain and anti-inflammation drugs slows the growth rate of a specific kind of cancer in animal models and suggests the medication could have the same effect on other types of tumors.

26 May 2016

Mice study shows heart medication helps reduce build-up of plaque in brain's blood vessels

A new study from örebro University, published in Science Signaling today, shows that heart medication reduces the build-up of plaque in the brain's blood vessels in mice. The question is if this is true also in humans? If the answer is yes, it might bring scientists a step closer to developing a medicine against Alzheimer's disease.

25 May 2016

Researchers discover how specific gene inhibits bacterial invasion of colonic epithelia

A group of researchers at Osaka University elucidated how a gene named Ly6/Plaur domain containing 8 (Lypd8) inhibits bacterial invasion of colonic epithelia, regulating intestinal inflammation. This achievement may lead to the development of drugs for ulcerative colitis.

25 May 2016

Continuous errors in damaged DNA repair may lead to tumor formation

A group of researchers at Osaka University found that if DNA damage response (DDR) does not work when DNA is damaged by radiation, proteins which should be removed remain instead, and a loss of genetic information can be incited, which, when repaired incorrectly, will lead to the tumor formation.

25 May 2016

Japanese scientists find evidence that cytokine IL-17A plays crucial role in psoriasis

Psoriasis is an inflammatory skin condition that affects some 125 million people worldwide. It is characterized by itchy, scaly skin plaques. The exact cause of psoriasis is unclear.

25 May 2016

WPI receives patent for novel method of reprogramming human skin cells

Cell therapies for a range of serious conditions, including heart attacks, diabetes, and traumatic injuries, will be accelerated by research at Worcester Polytechnic Institute that yielded a newly patented method of converting human skin cells into engines of wound healing and tissue regeneration.

25 May 2016

G Protein News and Research

TSRI scientists discover new method for harnessing venoms for therapeutic use

Alzheimer’s research raises questions on the role of infection

Researchers partially restore lost function of isolated cystic fibrosis lung cells

Majority of young adults with abdominal obesity unaware of CKD risk

Pre-treatment with antihistamines may suppress gastrointestinal symptoms of food allergy

First large-scale proteogenomic study helps pinpoint genes that drive breast cancer

SBP scientists discover new regulator of immune responses

Common pain and anti-inflammation drugs may slow cancer growth

Mice study shows heart medication helps reduce build-up of plaque in brain's blood vessels

Researchers discover how specific gene inhibits bacterial invasion of colonic epithelia

Continuous errors in damaged DNA repair may lead to tumor formation

Japanese scientists find evidence that cytokine IL-17A plays crucial role in psoriasis

WPI receives patent for novel method of reprogramming human skin cells

Sylvester researchers test new KTE-C19 therapy for patients with aggressive non-Hodgkin's lymphoma

New approach offers unprecedented view of how HIV virus infects and appropriates host cell

Single enzyme doing the work of a trio could offer precise way to treat diseases

Researchers discover new potential treatment target for liver cancer

Breakthrough study observes structural changes in carbonic anhydrase for first time

Novel strategy to predict antigenic evolution of circulating influenza viruses

Rare mutation may reduce risk of developing arteriosclerosis by 34%

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News